Patents by Inventor Silvia Bozza

Silvia Bozza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GALACTOSAMINOGALACTAN COMPRISING alpha-1-4 LINKED GALACTOSE AND alpha-1-4 LINKED N-ACETYLGALACTOSAMINE FOR USE IN THE TREATMENT OF AT LEAST ONE INFLAMMATORY DISEASE
    Publication number: 20160008391
    Abstract: A first object of the invention is galactosaminogalactan comprising ?1-4 linked galactose, ?1-4 linked N-acetylgalactosamine, and optionally ?1-4 linked galactosamine, for use in the treatment of at least one inflammatory disease. Another object of the invention is a pharmaceutical composition comprising a galactosaminogalactan comprising ?1-4 linked galactose, ?1-4 linked N-acetylgalactosamine, and optionally ?1-4 linked galactosamine, as defined herein, and optionally a pharmaceutically acceptable carrier. Another object of the invention is a pharmaceutical composition according to the invention, for use in the treatment of at least one inflammatory disease. Another object of the invention is an inhibitor of IL-1RA for use in the treatment of human fungal diseases. Another object of the invention is a pharmaceutical composition comprising an inhibitor of IL-1RA, and optionally a pharmaceutically acceptable carrier.
    Type: Application
    Filed: January 14, 2014
    Publication date: January 14, 2016
    Inventors: Jean-Paul LATGE, Thierry Vincent Gérard FONTAINE, Frank Leo VAN DE VEERDONK, Mark Sebastiaan GRESNIGT, Mihai NETEA, Leo AB JOOSTEN, Luigina ROMANI, Silvia BOZZA, Antonella DE LUCA
  • Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases
    Patent number: 8268304
    Abstract: It is described the use of the long pentraxin PTX3 (PTX3) or one of its functional derivatives, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation.
    Type: Grant
    Filed: February 15, 2011
    Date of Patent: September 18, 2012
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite SpA
    Inventors: Paolo Carminati, Marica Sassano, Francesco Bistoni, Luigina Romani, Silvia Bozza
  • USE OF THE LONG PENTRAXIN PTX3 FOR THE PREVENTION OR TREATMENT OF VIRAL DISEASES
    Publication number: 20110224132
    Abstract: It is described the use of the long pentraxin PTX3 (PTX3) or one of its functional derivatives, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation.
    Type: Application
    Filed: February 15, 2011
    Publication date: September 15, 2011
    Applicant: TECNOGEN S.P.A
    Inventors: Paolo Carminati, Marica Sassano, Francesco Bistoni, Luigina Romani, Silvia Bozza
  • Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases
    Patent number: 7910092
    Abstract: It is described the use of the long pentraxin PTX3 (PTX3) or one of its functional derivatives, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation.
    Type: Grant
    Filed: February 28, 2007
    Date of Patent: March 22, 2011
    Assignee: Tecnogen S.p.A.
    Inventors: Paolo Carminati, Marica Sassano, Francesco Bistoni, Luigina Romani, Silvia Bozza
  • USE OF THE LONG PENTRAXIN PTX3 FOR THE PREVENTION OR TREATMENT OF VIRAL DISEASES
    Publication number: 20090286726
    Abstract: It is described the use of the long pentraxin PTX3 (PTX3) or one of its functional derivatives, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation.
    Type: Application
    Filed: February 28, 2007
    Publication date: November 19, 2009
    Applicant: TECNOGEN S.P.A.
    Inventors: Paolo Carminati, Marica Sassano, Francesco Bistoni, Luigina Romani, Silvia Bozza